Modulating effects of olanzapine on the development of diabetic ketoacidosis [4]

Diabetic Medicine

Volumn 21, Issue 3, 2004, Pages 300-301

  Tsuchiyama, N ^a   Ando, H ^a   Ota, T ^a   Sakurai, M ^a   Takamura, T ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; OLANZAPINE;

BLOOD GAS ANALYSIS; CONFUSION; DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE URINE LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LETTER; MALAISE; METABOLIC ACIDOSIS; METABOLIC CLEARANCE RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; SCHIZOPHRENIA; THIRST; UPPER RESPIRATORY TRACT INFECTION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE;

EID: 1542314761     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01113.x     Document Type: Letter

References (6)

1. Beasley CM Jr, Tollefson GD, Tran PV. Efficacy of olanzapine: an overview of pivotal clinical trial. J Clin Psychiatry 1997; 10: 7-12.
2. Liebzeit KA, Markowitz JS, Caley CF. New onset diabetes and atypical antipsychotic. Eur Neuropsychopharmacol 2001; 11: 25-32.
3. Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 2001; 62: 92-100.
4. Sowell MO, Mukhopadhyay N, Cavazzoni P, Shanker S, Steinberg HO, Breier A et al. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. J Clin EndocrinolMetab 2002; 87: 2918-2923.
5. Koro CE, Fedder DO, L'Italien GJ, Weiss SS, Magder LS, Kreyenbuhl J et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population-based nested case-control study. BMJ 2002; 325: 243-247.
6. Caro JJ, Ward A, Levinton C, Robinson K. The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. J Clin Psychiatry 2002; 63: 1135-1139.